rs1159943880

Variant summary

Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM1PM5PP3_Strong

The ENST00000218104.6(ABCD1):​c.1567C>A​(p.Leu523Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000331 in 1,210,121 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L523P) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.000018 ( 0 hom., 1 hem., cov: 24)
Exomes 𝑓: 0.0000018 ( 0 hom. 1 hem. )

Consequence

ABCD1
ENST00000218104.6 missense

Scores

9
5
3

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:4

Conservation

PhyloP100: 1.42
Variant links:
Genes affected
ABCD1 (HGNC:61): (ATP binding cassette subfamily D member 1) The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ALD subfamily, which is involved in peroxisomal import of fatty acids and/or fatty acyl-CoAs in the organelle. All known peroxisomal ABC transporters are half transporters which require a partner half transporter molecule to form a functional homodimeric or heterodimeric transporter. This peroxisomal membrane protein is likely involved in the peroxisomal transport or catabolism of very long chain fatty acids. Defects in this gene have been identified as the underlying cause of adrenoleukodystrophy, an X-chromosome recessively inherited demyelinating disorder of the nervous system. [provided by RefSeq, Jul 2008]
PLXNB3-AS1 (HGNC:40454): (PLXNB3 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 8 ACMG points.

PM1
In a hotspot region, there are 6 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 5 uncertain in ENST00000218104.6
PM5
Other missense variant is known to change same aminoacid residue: Variant chrX-153740170-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 528338.Status of the report is criteria_provided_single_submitter, 1 stars.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.982

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ABCD1NM_000033.4 linkuse as main transcriptc.1567C>A p.Leu523Ile missense_variant 6/10 ENST00000218104.6 NP_000024.2
LOC124905226XR_007068350.1 linkuse as main transcriptn.1378G>T non_coding_transcript_exon_variant 1/2
ABCD1XM_047441916.1 linkuse as main transcriptc.1867C>A p.Leu623Ile missense_variant 7/11 XP_047297872.1
ABCD1XM_047441917.1 linkuse as main transcriptc.1623C>A p.Gly541= synonymous_variant 7/8 XP_047297873.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ABCD1ENST00000218104.6 linkuse as main transcriptc.1567C>A p.Leu523Ile missense_variant 6/101 NM_000033.4 ENSP00000218104 P1
PLXNB3-AS1ENST00000434284.1 linkuse as main transcriptn.72-1592G>T intron_variant, non_coding_transcript_variant 3
ABCD1ENST00000443684.2 linkuse as main transcriptn.570C>A non_coding_transcript_exon_variant 5/63

Frequencies

GnomAD3 genomes
AF:
0.0000177
AC:
2
AN:
112922
Hom.:
0
Cov.:
24
AF XY:
0.0000285
AC XY:
1
AN XY:
35068
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000375
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000182
AC:
2
AN:
1097199
Hom.:
0
Cov.:
32
AF XY:
0.00000276
AC XY:
1
AN XY:
362631
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000238
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000177
AC:
2
AN:
112922
Hom.:
0
Cov.:
24
AF XY:
0.0000285
AC XY:
1
AN XY:
35068
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000375
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000142
Hom.:
1
Bravo
AF:
0.00000378

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingGeneDxSep 10, 2020Has not been previously published as pathogenic or benign to our knowledge; In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function -
Uncertain significance, criteria provided, single submitterclinical testingRevvity Omics, RevvityJan 26, 2023- -
Adrenoleukodystrophy Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJul 28, 2023In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Leu523 amino acid residue in ABCD1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 21700483). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ABCD1 protein function. ClinVar contains an entry for this variant (Variation ID: 1213423). This sequence change replaces leucine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 523 of the ABCD1 protein (p.Leu523Ile). This variant is present in population databases (no rsID available, gnomAD 0.01%), including at least one homozygous and/or hemizygous individual. This variant has not been reported in the literature in individuals affected with ABCD1-related conditions. -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 25, 2022The c.1567C>A (p.L523I) alteration is located in exon 6 (coding exon 6) of the ABCD1 gene. This alteration results from a C to A substitution at nucleotide position 1567, causing the leucine (L) at amino acid position 523 to be replaced by an isoleucine (I). Based on data from gnomAD, the A allele has an overall frequency of 0.005% (1/21901) total alleles studied, with 1 hemizygote(s) observed. The highest observed frequency was 0.009% (1/10749) of European (non-Finnish) alleles. This amino acid position is highly conserved in available vertebrate species. Based on internal structural analysis, L523I is located near an interface, is moderately destabilizing to the local structure, and has nearby pathogenic variants with no nearby benign variants (Ambry internal analysis). The in silico prediction for this alteration is inconclusive. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
ABCD1-related disorder Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesMar 07, 2024The ABCD1 c.1567C>A variant is predicted to result in the amino acid substitution p.Leu523Ile. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0093% of alleles in individuals of European (non-Finnish) descent in gnomAD. An alternative nucleotide substitution affecting the same amino acid (p.Leu523Phe) has been reported to have arisen de novo in an individual with X-linked adrenoleukodystrophy (Table 2, Wang et al. 2011. PubMed ID: 21700483). Although we suspect that the c.1567C>A (p.Leu523Ile) variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.48
BayesDel_addAF
Pathogenic
0.37
D
BayesDel_noAF
Pathogenic
0.29
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.85
D
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Pathogenic
0.99
D
M_CAP
Pathogenic
0.66
D
MetaRNN
Pathogenic
0.98
D
MetaSVM
Pathogenic
0.96
D
MutationAssessor
Benign
1.6
L
MutationTaster
Benign
1.0
D
PrimateAI
Uncertain
0.63
T
PROVEAN
Benign
-1.8
N
REVEL
Pathogenic
0.75
Sift
Pathogenic
0.0
D
Sift4G
Uncertain
0.0050
D
Polyphen
1.0
D
Vest4
0.65
MutPred
0.89
Loss of phosphorylation at Y527 (P = 0.1346);
MVP
0.98
MPC
1.6
ClinPred
0.95
D
GERP RS
4.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.79
gMVP
0.84

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1159943880; hg19: chrX-153005624; API